Leptin may contribute to hyperlipidemia through the OB-R-mediated activation of the JAK2/STAT3 pathway, which affects lipid metabolism and fat deposition in hepatic tissue (Wu et al. 2017; Gao et al. 2009; Chen et al. 2019). Here, JAK2 is linked to hyperlipidemia.